|
|
|
1
|
Kaufman DW, Kelly JP, Issaragrisil S, Laporte JR, Anderson T, Levy M, Shapiro S, Young NS.
Relative incidence of agranulocytosis and aplastic anemia.
Am J Hematol 81(1): 65-7, 2006.
[Text Abstract on PubMed]
|
|
|
2
|
Sloand EM, Scheinberg P, Maciejewski J, Young NS.
Brief communication: successful treatment of pure red-cell aplasia with an anti-interleukin-2 receptor antibody (daclizumab).
Ann Intern Med 144(3): 181-5, 2006.
[Text Abstract on PubMed]
|
|
|
3
|
Solomou EE, Keyvanfar K, Young NS.
T-bet, a Th1 transcription factor, is up-regulated in T cells from patients with aplastic anemia.
Blood: 2006.
[Text Abstract on PubMed]
|
|
|
4
|
Zeng W, Miyazato A, Chen G, Kajigaya S, Young NS, Maciejewski JP.
Interferon-gamma-induced gene expression in CD34 cells: identification of pathologic cytokine-specific signature profiles.
Blood 107(1): 167-75, 2006.
[Text Abstract on PubMed]
|
|
|
5
|
Chen J, Brandt JS, Ellison FM, Calado RT, Young NS.
Defective stromal cell function in a mouse model of infusion-induced bone marrow failure.
Exp Hematol 33(8): 901-8, 2005.
[Text Abstract on PubMed]
|
|
|
6
|
Issaragrisil S, Kaufman DW, Anderson T, Chansung K, Leaverton PE, Shapiro S, Young NS.
The epidemiology of aplastic anemia in thailand.
Blood: 2005.
[Text Abstract on PubMed]
|
|
|
7
|
Ly H, Calado RT, Allard P, Baerlocher GM, Lansdorp PM, Young NS, Parslow TG.
Functional characterization of telomerase RNA variants found in patients with hematologic disorders.
Blood 105(6): 2332-9, 2005.
[Text Abstract on PubMed]
|
|
|
8
|
Ogasawara Y, Nakayama K, Tarnowka M, McCoy JP, Kajigaya S, Levin BC, Young NS.
Mitochondrial DNA spectra of single human CD34+ cells, T cells, B cells, and granulocytes.
Blood 106(9): 3271-84, 2005.
[Text Abstract on PubMed]
|
|
|
9
|
Ramkissoon SH, Mainwaring LA, Ogasawara Y, Keyvanfar K, Philip McCoy J, Sloand EM, Kajigaya S, Young NS.
Hematopoietic-specific microRNA expression in human cells.
Leuk Res: 2005.
[Text Abstract on PubMed]
|
|
|
10
|
Ramkissoon SH, Mainwaring LA, Sloand EM, Young NS, Kajigaya S.
Nonisotopic detection of microRNA using digoxigenin labeled RNA probes.
Mol Cell Probes: 2005.
[Text Abstract on PubMed]
|
|
|
11
|
Sloand EM, Mainwaring L, Fuhrer M, Ramkissoon S, Risitano AM, Keyvanafar K, Lu J, Basu A, Barrett AJ, Young NS.
Preferential suppression of trisomy 8 compared with normal hematopoietic cell growth by autologous lymphocytes in patients with trisomy 8 myelodysplastic syndrome.
Blood 106(3): 841-51, 2005.
[Text Abstract on PubMed]
|
|
|
12
|
Yamaguchi H, Calado RT, Ly H, Kajigaya S, Baerlocher GM, Chanock SJ, Lansdorp PM, Young NS.
Mutations in TERT, the gene for telomerase reverse transcriptase, in aplastic anemia.
N Engl J Med 352(14): 1413-24, 2005.
[Text Abstract on PubMed]
|
|
|
13
|
Young NS.
Paroxysmal nocturnal hemoglobinuria: current issues in pathophysiology and treatment.
Curr Hematol Rep 4(2): 103-9, 2005.
[Text Abstract on PubMed]
|
|
|
14
|
Bloom ML, Wolk AG, Simon-Stoos KL, Bard JS, Chen J, Young NS.
A mouse model of lymphocyte infusion-induced bone marrow failure.
Exp Hematol 32(12): 1163-72, 2004.
[Text Abstract on PubMed]
|
|
|
15
|
Chen G, Kook H, Zeng W, Young NS, Maciejewski JP.
Is there a direct effect of antithymocyte globulin on hematopoiesis?
Hematol J 5(3): 255-61, 2004.
[Text Abstract on PubMed]
|
|
|
16
|
Chen G, Zeng W, Green S, Young NS.
Frequent HPRT mutations in paroxysmal nocturnal haemoglobinuria reflect T cell clonal expansion, not genomic instability.
Br J Haematol 125(3): 383-91, 2004.
[Text Abstract on PubMed]
|
|
|
17
|
Chen G, Zeng W, Miyazato A, Billings E, Maciejewski JP, Kajigaya S, Sloand EM, Young NS.
Distinctive gene expression profiles of CD34 cells from patients with myelodysplastic syndrome characterized by specific chromosomal abnormalities.
Blood 104(13): 4210-8, 2004.
[Text Abstract on PubMed]
|
|
|
18
|
Chen J, Lipovsky K, Ellison FM, Calado RT, Young NS.
Bystander destruction of hematopoietic progenitor and stem cells in a mouse model of infusion-induced bone marrow failure.
Blood 104(6): 1671-8, 2004.
[Text Abstract on PubMed]
|
|
|
19
|
Kearns WG, Sutton JF, Maciejewski JP, Young NS, Liu JM.
Genomic instability in bone marrow failure syndromes.
Am J Hematol 76(3): 220-4, 2004.
[Text Abstract on PubMed]
|
|
|
20
|
Kearns WG, Yamaguchi H, Young NS, Liu JM.
Centrosome amplification and aneuploidy in bone marrow failure patients.
Genes Chromosomes Cancer 40(4): 329-33, 2004.
[Text Abstract on PubMed]
|
|
|
21
|
Lu J, Basu A, Melenhorst JJ, Young NS, Brown KE.
Analysis of T-cell repertoire in hepatitis-associated aplastic anemia.
Blood 103(12): 4588-93, 2004.
[Text Abstract on PubMed]
|
|
|
22
|
Shin MG, Kajigaya S, McCoy JP, Levin BC, Young NS.
Marked mitochondrial DNA sequence heterogeneity in single CD34+ cell clones from normal adult bone marrow.
Blood 103(2): 553-61, 2004.
[Text Abstract on PubMed]
|
|
|
23
|
Shin MG, Kajigaya S, Tarnowka M, McCoy JP, Levin BC, Young NS.
Mitochondrial DNA sequence heterogeneity in circulating normal human CD34 cells and granulocytes.
Blood 103(12): 4466-77, 2004.
[Text Abstract on PubMed]
|
|
|
24
|
Simak J, Holada K, Risitano AM, Zivny JH, Young NS, Vostal JG.
Elevated circulating endothelial membrane microparticles in paroxysmal nocturnal haemoglobinuria.
Br J Haematol 125(6): 804-13, 2004.
[Text Abstract on PubMed]
|
|
|
25
|
Sloand EM, Mainwaring L, Keyvanfar K, Chen J, Maciejewski J, Klein HG, Young NS.
Transfer of glycosylphosphatidylinositol-anchored proteins to deficient cells after erythrocyte transfusion in paroxysmal nocturnal hemoglobinuria.
Blood 104(12): 3782-8, 2004.
[Text Abstract on PubMed]
|
|
|
26
|
Sutton JF, Stacey M, Kearns WG, Rieg TS, Young NS, Liu JM.
Increased risk for aplastic anemia and myelodysplastic syndrome in individuals lacking glutathione S-transferase genes.
Pediatr Blood Cancer 42(2): 122-6, 2004.
[Text Abstract on PubMed]
|
|
|
27
|
Takahashi Y, McCoy JP, Carvallo C, Rivera C, Igarashi T, Srinivasan R, Young NS, Childs RW.
In vitro and in vivo evidence of PNH cell sensitivity to immune attack after nonmyeloablative allogeneic hematopoietic cell transplantation.
Blood 103(4): 1383-90, 2004.
[Text Abstract on PubMed]
|
|
|
28
|
Young NS, Brown KE.
Parvovirus B19.
N Engl J Med 350(6): 586-97, 2004.
[Text Abstract on PubMed]
|
|
|
29
|
Zeng W, Chen G, Kajigaya S, Nunez O, Charrow A, Billings EM, Young NS.
Gene expression profiling in CD34 cells to identify differences between aplastic anemia patients and healthy volunteers.
Blood 103(1): 325-32, 2004.
[Text Abstract on PubMed]
|
|
|
30
|
Zeng W, Kajigaya S, Chen G, Risitano AM, Nunez O, Young NS.
Transcript profile of CD4+ and CD8+ T cells from the bone marrow of acquired aplastic anemia patients.
Exp Hematol 32(9): 806-14, 2004.
[Text Abstract on PubMed]
|
|
|
31
|
Ballou WR, Reed JL, Noble W, Young NS, Koenig S.
Safety and immunogenicity of a recombinant parvovirus B19 vaccine formulated with MF59C.1.
J Infect Dis 187(4): 675-8, 2003.
[Text Abstract on PubMed]
|
|
|
32
|
Battiwalla M, Melenhorst J, Saunthararajah Y, Nakamura R, Molldrem J, Young NS, Barrett AJ.
HLA-DR4 predicts haematological response to cyclosporine in T-large granular lymphocyte lymphoproliferative disorders.
Br J Haematol 123(3): 449-53, 2003.
[Text Abstract on PubMed]
|
|
|
33
|
Fogarty PF, Yamaguchi H, Wiestner A, Baerlocher GM, Sloand E, Zeng WS, Read EJ, Lansdorp PM, Young NS.
Late presentation of dyskeratosis congenita as apparently acquired aplastic anaemia due to mutations in telomerase RNA.
Lancet 362(9396): 1628-30, 2003.
[Text Abstract on PubMed]
|
|
|
34
|
Maciejewski JP, Sloand EM, Nunez O, Boss C, Young NS.
Recombinant humanized anti-IL-2 receptor antibody (daclizumab) produces responses in patients with moderate aplastic anemia.
Blood 102(10): 3584-6, 2003.
[Text Abstract on PubMed]
|
|
|
35
|
Risitano AM, Holada K, Chen G, Simak J, Vostal JG, Young NS, Maciejewski JP.
CD34+ cells from paroxysmal nocturnal hemoglobinuria (PNH) patients are deficient in surface expression of cellular prion protein (PrPc).
Exp Hematol 31(1): 65-72, 2003.
[Text Abstract on PubMed]
|
|
|
36
|
Rosenfeld S, Follmann D, Nunez O, Young NS.
Antithymocyte globulin and cyclosporine for severe aplastic anemia: association between hematologic response and long-term outcome.
JAMA 289(9): 1130-5, 2003.
[Text Abstract on PubMed]
|
|
|
37
|
Shin MG, Kajigaya S, Levin BC, Young NS.
Mitochondrial DNA mutations in patients with myelodysplastic syndromes.
Blood 101(8): 3118-25, 2003.
[Text Abstract on PubMed]
|
|
|
38
|
Sloand E, Childs RW, Solomon S, Greene A, Young NS, Barrett AJ.
The graft-versus-leukemia effect of nonmyeloablative stem cell allografts may not be sufficient to cure chronic myelogenous leukemia.
Bone Marrow Transplant 32(9): 897-901, 2003.
[Text Abstract on PubMed]
|
|
|
39
|
Sloand EM, Fuhrer M, Keyvanfar K, Mainwaring L, Maciejewski J, Wang Y, Johnson S, Barrett AJ, Young NS.
Cytogenetic abnormalities in paroxysmal nocturnal haemoglobinuria usually occur in haematopoietic cells that are glycosylphosphatidylinositol-anchored protein (GPI-AP) positive.
Br J Haematol 123(1): 173-6, 2003.
[Text Abstract on PubMed]
|
|
|
40
|
Solomon SR, Nakamura R, Read EJ, Leitman SF, Carter C, Childs R, Dunbar CE, Young NS, Barrett AJ.
Cyclosporine is required to prevent severe acute GVHD following T-cell-depleted peripheral blood stem cell transplantation.
Bone Marrow Transplant 31(9): 783-8, 2003.
[Text Abstract on PubMed]
|
|
|
41
|
Umemura T, Tanaka E, Ostapowicz G, Brown KE, Heringlake S, Tassopoulos NC, Wang RY, Yeo AE, Shih JW, Orii K, Young NS, Hatzakis A, Manns MP, Lee WM, Kiyosawa K, Alter HJ.
Investigation of SEN virus infection in patients with cryptogenic acute liver failure, hepatitis-associated aplastic anemia, or acute and chronic non-A-E hepatitis.
J Infect Dis 188(10): 1545-52, 2003.
[Text Abstract on PubMed]
|
|
|
42
|
Wong S, Young NS, Brown KE.
Prevalence of parvovirus B19 in liver tissue: no association with fulminant hepatitis or hepatitis-associated aplastic anemia.
J Infect Dis 187(10): 1581-6, 2003.
[Text Abstract on PubMed]
|
|
|
43
|
Yamaguchi H, Baerlocher GM, Lansdorp PM, Chanock SJ, Nunez O, Sloand E, Young NS.
Mutations of the human telomerase RNA gene (TERC) in aplastic anemia and myelodysplastic syndrome.
Blood 102(3): 916-8, 2003.
[Text Abstract on PubMed]
|
|
|
44
|
Chen G, Kirby M, Zeng W, Young NS, Maciejewski JP.
Superior growth of glycophosphatidy linositol-anchored protein-deficient progenitor cells in vitro is due to the higher apoptotic rate of progenitors with normal phenotype in vivo.
Exp Hematol 30(7): 774-82, 2002.
[Text Abstract on PubMed]
|
|
|
45
|
Greenberg PL, Young NS, Gattermann N.
Myelodysplastic syndromes.
Hematology (Am Soc Hematol Educ Program): 136-61, 2002.
[Text Abstract on PubMed]
|
|
|
46
|
Holada K, Simak J, Risitano AM, Maciejewski J, Young NS, Vostal JG.
Activated platelets of patients with paroxysmal nocturnal hemoglobinuria express cellular prion protein.
Blood 100(1): 341-3, 2002.
[Text Abstract on PubMed]
|
|
|
47
|
Kook H, Risitano AM, Zeng W, Wlodarski M, Lottemann C, Nakamura R, Barrett J, Young NS, Maciejewski JP.
Changes in T-cell receptor VB repertoire in aplastic anemia: effects of different immunosuppressive regimens.
Blood 99(10): 3668-75, 2002.
[Text Abstract on PubMed]
|
|
|
48
|
Maciejewski JP, Risitano A, Kook H, Zeng W, Chen G, Young NS.
Immune pathophysiology of aplastic anemia.
Int J Hematol 76 Suppl 1: 207-14, 2002.
[Text Abstract on PubMed]
|
|
|
49
|
Maciejewski JP, Risitano A, Sloand EM, Nunez O, Young NS.
Distinct clinical outcomes for cytogenetic abnormalities evolving from aplastic anemia.
Blood 99(9): 3129-35, 2002.
[Text Abstract on PubMed]
|
|
|
50
|
Maciejewski JP, Risitano AM, Sloand EM, Wisch L, Geller N, Barrett JA, Young NS, Ristiano AM.
A pilot study of the recombinant soluble human tumour necrosis factor receptor (p75)-Fc fusion protein in patients with myelodysplastic syndrome.
Br J Haematol 117(1): 119-26, 2002.
[Text Abstract on PubMed]
|
|
|
51
|
Molldrem JJ, Leifer E, Bahceci E, Saunthararajah Y, Rivera M, Dunbar C, Liu J, Nakamura R, Young NS, Barrett AJ.
Antithymocyte globulin for treatment of the bone marrow failure associated with myelodysplastic syndromes.
Ann Intern Med 137(3): 156-63, 2002.
[Text Abstract on PubMed]
|
|
|
52
|
Nagakura S, Ishihara S, Dunn DE, Nishimura J, Kawaguchi T, Horikawa K, Hidaka M, Kagimoto T, Eto N, Mitsuya H, Kinoshita T, Young NS, Nakakuma H.
Decreased susceptibility of leukemic cells with PIG-A mutation to natural killer cells in vitro.
Blood 100(3): 1031-7, 2002.
[Text Abstract on PubMed]
|
|
|
53
|
Risitano AM, Kook H, Zeng W, Chen G, Young NS, Maciejewski JP.
Oligoclonal and polyclonal CD4 and CD8 lymphocytes in aplastic anemia and paroxysmal nocturnal hemoglobinuria measured by V beta CDR3 spectratyping and flow cytometry.
Blood 100(1): 178-83, 2002.
[Text Abstract on PubMed]
|
|
|
54
|
Saunthararajah Y, Nakamura R, Nam JM, Robyn J, Loberiza F, Maciejewski JP, Simonis T, Molldrem J, Young NS, Barrett AJ.
HLA-DR15 (DR2) is overrepresented in myelodysplastic syndrome and aplastic anemia and predicts a response to immunosuppression in myelodysplastic syndrome.
Blood 100(5): 1570-4, 2002.
[Text Abstract on PubMed]
|
|
|
55
|
Sloand E, Kim S, Maciejewski JP, Tisdale J, Follmann D, Young NS.
Intracellular interferon-gamma in circulating and marrow T cells detected by flow cytometry and the response to immunosuppressive therapy in patients with aplastic anemia.
Blood 100(4): 1185-91, 2002.
[Text Abstract on PubMed]
|
|
|
56
|
Sloand EM, Kim S, Fuhrer M, Risitano AM, Nakamura R, Maciejewski JP, Barrett AJ, Young NS.
Fas-mediated apoptosis is important in regulating cell replication and death in trisomy 8 hematopoietic cells but not in cells with other cytogenetic abnormalities.
Blood 100(13): 4427-32, 2002.
[Text Abstract on PubMed]
|
|
|
57
|
Tisdale JF, Maciejewski JP, Nuñez O, Rosenfeld SJ, Young NS.
Late complications following treatment for severe aplastic anemia (SAA) with high-dose cyclophosphamide (Cy): follow-up of a randomized trial.
Blood 100(13): 4668-70, 2002.
[Text Abstract on PubMed]
|
|
|
58
|
Young NS, Maciejewski JP, Sloand E, Chen G, Zeng W, Risitano A, Miyazato A.
The relationship of aplastic anemia and PNH.
Int J Hematol 76 Suppl 2: 168-72, 2002.
[Text Abstract on PubMed]
|
|
|
59
|
Young NS, Tisdale JF.
High-dose cyclophosphamide for treatment of aplastic anemia.
Ann Intern Med 137(6): 549-50; author reply 549-50, 2002.
[Text Abstract on PubMed]
|
|
|
60
|
Young NS.
Acquired aplastic anemia.
Ann Intern Med 136(7): 534-46, 2002.
[Text Abstract on PubMed]
|
|
|
61
|
Young NS.
Immunosuppressive treatment of acquired aplastic anemia and immune-mediated bone marrow failure syndromes.
Int J Hematol 75(2): 129-40, 2002.
[Text Abstract on PubMed]
|
|
|
62
|
Zeng W, Maciejewski JP, Chen G, Risitano AM, Kirby M, Kajigaya S, Young NS.
Selective reduction of natural killer T cells in the bone marrow of aplastic anaemia.
Br J Haematol 119(3): 803-9, 2002.
[Text Abstract on PubMed]
|
|
|
63
|
Brennan MT, Sankar V, Baccaglini L, Pillemer SR, Kingman A, Nunez O, Young NS, Atkinson JC.
Oral manifestations in patients with aplastic anemia.
Oral Surg Oral Med Oral Pathol Oral Radiol Endod 92(5): 503-8, 2001.
[Text Abstract on PubMed]
|
|
|
64
|
Brown KE, Young NS, Alving BM, Barbosa LH.
Parvovirus B19: implications for transfusion medicine. Summary of a workshop.
Transfusion 41(1): 130-5, 2001.
[Text Abstract on PubMed]
|
|
|
65
|
Brümmendorf TH, Maciejewski JP, Mak J, Young NS, Lansdorp PM.
Telomere length in leukocyte subpopulations of patients with aplastic anemia.
Blood 97(4): 895-900, 2001.
[Text Abstract on PubMed]
|
|
|
66
|
Kook H, Zeng W, Guibin C, Kirby M, Young NS, Maciejewski JP.
Increased cytotoxic T cells with effector phenotype in aplastic anemia and myelodysplasia.
Exp Hematol 29(11): 1270-7, 2001.
[Text Abstract on PubMed]
|
|
|
67
|
Maciejewski JP, Follmann D, Nakamura R, Saunthararajah Y, Rivera CE, Simonis T, Brown KE, Barrett JA, Young NS.
Increased frequency of HLA-DR2 in patients with paroxysmal nocturnal hemoglobinuria and the PNH/aplastic anemia syndrome.
Blood 98(13): 3513-9, 2001.
[Text Abstract on PubMed]
|
|
|
68
|
Maciejewski JP, Rivera C, Kook H, Dunn D, Young NS.
Relationship between bone marrow failure syndromes and the presence of glycophosphatidyl inositol-anchored protein-deficient clones.
Br J Haematol 115(4): 1015-22, 2001.
[Text Abstract on PubMed]
|
|
|
69
|
Nakamura R, Bahceci E, Read EJ, Leitman SF, Carter CS, Childs R, Dunbar CE, Gress R, Altemus R, Young NS, Barrett AJ.
Transplant dose of CD34(+) and CD3(+) cells predicts outcome in patients with haematological malignancies undergoing T cell-depleted peripheral blood stem cell transplants with delayed donor lymphocyte add-back.
Br J Haematol 115(1): 95-104, 2001.
[Text Abstract on PubMed]
|
|
|
70
|
Saunthararajah Y, Molldrem JL, Rivera M, Williams A, Stetler-Stevenson M, Sorbara L, Young NS, Barrett JA.
Coincident myelodysplastic syndrome and T-cell large granular lymphocytic disease: clinical and pathophysiological features.
Br J Haematol 112(1): 195-200, 2001.
[Text Abstract on PubMed]
|
|
|
71
|
Zeng W, Maciejewski JP, Chen G, Young NS.
Limited heterogeneity of T cell receptor BV usage in aplastic anemia.
J Clin Invest 108(5): 765-73, 2001.
[Text Abstract on PubMed]
|
|
|
72
|
Bahçeci E, Read EJ, Leitman S, Childs R, Dunbar C, Young NS, Barrett AJ.
CD34+ cell dose predicts relapse and survival after T-cell-depleted HLA-identical haematopoietic stem cell transplantation (HSCT) for haematological malignancies.
Br J Haematol 108(2): 408-14, 2000.
[Text Abstract on PubMed]
|
|
|
73
|
Brown KE, Young NS.
Epidemiology and pathology of erythroviruses.
Contrib Microbiol 4: 107-22, 2000.
[Text Abstract on PubMed]
|
|
|
74
|
Childs R, Chernoff A, Contentin N, Bahceci E, Schrump D, Leitman S, Read EJ, Tisdale J, Dunbar C, Linehan WM, Young NS, Barrett AJ.
Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation.
N Engl J Med 343(11): 750-8, 2000.
[Text Abstract on PubMed]
|
|
|
75
|
Giri N, Kang E, Tisdale JF, Follman D, Rivera M, Schwartz GN, Kim S, Young NS, Rick ME, Dunbar CE.
Clinical and laboratory evidence for a trilineage haematopoietic defect in patients with refractory Diamond-Blackfan anaemia.
Br J Haematol 108(1): 167-75, 2000.
[Text Abstract on PubMed]
|
|
|
76
|
Handa A, Dickstein B, Young NS, Brown KE.
Prevalence of the newly described human circovirus, TTV, in United States blood donors.
Transfusion 40(2): 245-51, 2000.
[Text Abstract on PubMed]
|
|
|
77
|
Handa A, Jubran RF, Dickstein B, Boylan A, Luban NL, Young NS, Brown KE.
GB virus C/Hepatitis G virus infection is frequent in American children and young adults.
Clin Infect Dis 30(3): 569-71, 2000.
[Text Abstract on PubMed]
|
|
|
78
|
Liu Z, Donahue RE, Young NS, Brown KE.
Sequencing and characterization of A-2 plaque virus: A new member of the Picornaviridae family.
Virology 272(1): 168-76, 2000.
[Text Abstract on PubMed]
|
|
|
79
|
Maciejewski JP, Kim S, Sloand E, Selleri C, Young NS.
Sustained long-term hematologic recovery despite a marked quantitative defect in the stem cell compartment of patients with aplastic anemia after immunosuppressive therapy.
Am J Hematol 65(2): 123-31, 2000.
[Text Abstract on PubMed]
|
|
|
80
|
Robinson MR, Fine HF, Ross ML, Mont EK, Bryant-Greenwood PK, Hertle RW, Tisdale JF, Young NS, Zeichner SL, Van Waes C, Whitcup SM, Walsh TJ.
Sino-orbital-cerebral aspergillosis in immunocompromised pediatric patients.
Pediatr Infect Dis J 19(12): 1197-203, 2000.
[Text Abstract on PubMed]
|
|
|
81
|
Sloand EM, Kim S, Maciejewski JP, Van Rhee F, Chaudhuri A, Barrett J, Young NS.
Pharmacologic doses of granulocyte colony-stimulating factor affect cytokine production by lymphocytes in vitro and in vivo.
Blood 95(7): 2269-74, 2000.
[Text Abstract on PubMed]
|
|
|
82
|
Tisdale JF, Dunn DE, Geller N, Plante M, Nunez O, Dunbar CE, Barrett AJ, Walsh TJ, Rosenfeld SJ, Young NS.
High-dose cyclophosphamide in severe aplastic anaemia: a randomised trial.
Lancet 356(9241): 1554-9, 2000.
[Text Abstract on PubMed]
|
|
|
83
|
Young NS, Abkowitz JL, Luzzatto L.
New Insights into the Pathophysiology of Acquired Cytopenias.
Hematology (Am Soc Hematol Educ Program): 18-38, 2000.
[Text Abstract on PubMed]
|
|
|
84
|
Young NS, Maciejewski JP.
Genetic and environmental effects in paroxysmal nocturnal hemoglobinuria: this little PIG-A goes "Why? Why? Why?".
J Clin Invest 106(5): 637-41, 2000.
[Text Abstract on PubMed]
|
|
|
85
|
Young NS.
Hematopoietic cell destruction by immune mechanisms in acquired aplastic anemia.
Semin Hematol 37(1): 3-14, 2000.
[Text Abstract on PubMed]
|
|
|
86
|
Young NS.
Introduction: acquired aplastic anemia.
Semin Hematol 37(1): 2, 2000.
[Text Abstract on PubMed]
|
|
|
87
|
Bostic JR, Brown KE, Young NS, Koenig S.
Quantitative analysis of neutralizing immune responses to human parvovirus B19 using a novel reverse transcriptase-polymerase chain reaction-based assay.
J Infect Dis 179(3): 619-26, 1999.
[Text Abstract on PubMed]
|
|
|
88
|
Childs R, Clave E, Contentin N, Jayasekera D, Hensel N, Leitman S, Read EJ, Carter C, Bahceci E, Young NS, Barrett AJ.
Engraftment kinetics after nonmyeloablative allogeneic peripheral blood stem cell transplantation: full donor T-cell chimerism precedes alloimmune responses.
Blood 94(9): 3234-41, 1999.
[Text Abstract on PubMed]
|
|
|
89
|
Dunn DE, Tanawattanacharoen P, Boccuni P, Nagakura S, Green SW, Kirby MR, Kumar MS, Rosenfeld S, Young NS.
Paroxysmal nocturnal hemoglobinuria cells in patients with bone marrow failure syndromes.
Ann Intern Med 131(6): 401-8, 1999.
[Text Abstract on PubMed]
|
|
|
90
|
Dunn DE, Ware RE, Parker CJ, Mishoe HO, Young NS.
Research directions in paroxysmal nocturnal hemoglobinuria.
Immunol Today 20(4): 168-71, 1999.
[Text Abstract on PubMed]
|
|
|
91
|
Gigler A, Dorsch S, Hemauer A, Williams C, Kim S, Young NS, Zolla-Pazner S, Wolf H, Gorny MK, Modrow S.
Generation of neutralizing human monoclonal antibodies against parvovirus B19 proteins.
J Virol 73(3): 1974-9, 1999.
[Text Abstract on PubMed]
|
|
|
92
|
Issaragrisil S, Leaverton PE, Chansung K, Thamprasit T, Porapakham Y, Vannasaeng S, Piankijagum A, Kaufman DW, Anderson TE, Shapiro S, Young NS.
Regional patterns in the incidence of aplastic anemia in Thailand. The Aplastic Anemia Study Group.
Am J Hematol 61(3): 164-8, 1999.
[Text Abstract on PubMed]
|
|
|
93
|
Liu JM, Kim S, Read EJ, Futaki M, Dokal I, Carter CS, Leitman SF, Pensiero M, Young NS, Walsh CE.
Engraftment of hematopoietic progenitor cells transduced with the Fanconi anemia group C gene (FANCC).
Hum Gene Ther 10(14): 2337-46, 1999.
[Text Abstract on PubMed]
|
|
|
94
|
Shapiro S, Issaragrisil S, Kaufman DW, Anderson T, Chansung K, Thamprasit T, Sirijirachai J, Piankijagum A, Porapakkham Y, Vannasaeng S, Leaverton PE, Young NS.
Agranulocytosis in Bangkok, Thailand: a predominantly drug-induced disease with an unusually low incidence. Aplastic Anemia Study Group.
Am J Trop Med Hyg 60(4): 573-7, 1999.
[Text Abstract on PubMed]
|
|
|
95
|
Sloand EM, Kumar PN, Kim S, Chaudhuri A, Weichold FF, Young NS.
Human immunodeficiency virus type 1 protease inhibitor modulates activation of peripheral blood CD4(+) T cells and decreases their susceptibility to apoptosis in vitro and in vivo.
Blood 94(3): 1021-7, 1999.
[Text Abstract on PubMed]
|
|
|
96
|
Young NS.
Acquired aplastic anemia.
JAMA 282(3): 271-8, 1999.
[Text Abstract on PubMed]
|
|
|
97
|
Yu JM, Emmons RV, Hanazono Y, Sellers S, Young NS, Dunbar CE.
Expression of interferon-gamma by stromal cells inhibits murine long-term repopulating hematopoietic stem cell activity.
Exp Hematol 27(5): 895-903, 1999.
[Text Abstract on PubMed]
|
|
|
98
|
Barrett AJ, Mavroudis D, Tisdale J, Molldrem J, Clave E, Dunbar C, Cottler-Fox M, Phang S, Carter C, Okunnieff P, Young NS, Read EJ.
T cell-depleted bone marrow transplantation and delayed T cell add-back to control acute GVHD and conserve a graft-versus-leukemia effect.
Bone Marrow Transplant 21(6): 543-51, 1998.
[Text Abstract on PubMed]
|
|
|
99
|
Sato T, Kim S, Selleri C, Young NS, Maciejewski JP.
Measurement of secondary colony formation after 5 weeks in long-term cultures in patients with myelodysplastic syndrome.
Leukemia 12(8): 1187-94, 1998.
[Text Abstract on PubMed]
|
|
|
100
|
Sloand EM, Maciejewski JP, Dunn D, Moss J, Brewer B, Kirby M, Young NS.
Correction of the PNH defect by GPI-anchored protein transfer.
Blood 92(11): 4439-45, 1998.
[Text Abstract on PubMed]
|
|
|
101
|
Sloand EM, Maciejewski JP, Sato T, Bruny J, Kumar P, Kim S, Weichold FF, Young NS.
The role of interleukin-converting enzyme in Fas-mediated apoptosis in HIV-1 infection.
J Clin Invest 101(1): 195-201, 1998.
[Text Abstract on PubMed]
|
|
|
102
|
Sloand EM, Young NS, Sato T, Kim S, Maciejewski JP.
Inhibition of interleukin-1beta-converting enzyme in human hematopoietic progenitor cells results in blockade of cytokine-mediated apoptosis and expansion of their proliferative potential.
Exp Hematol 26(11): 1093-9, 1998.
[Text Abstract on PubMed]
|
|
|
103
|
Weichold FF, Zella D, Barabitskaja O, Maciejewski JP, Dunn DE, Sloand EM, Young NS.
Neither human immunodeficiency virus-1 (HIV-1) nor HIV-2 infects most-primitive human hematopoietic stem cells as assessed in long-term bone marrow cultures.
Blood 91(3): 907-15, 1998.
[Text Abstract on PubMed]
|
|
|
104
|
Abkowitz JL, Brown KE, Wood RW, Kovach NL, Green SW, Young NS.
Clinical relevance of parvovirus B19 as a cause of anemia in patients with human immunodeficiency virus infection.
J Infect Dis 176(1): 269-73, 1997.
[Text Abstract on PubMed]
|
|
|
105
|
Brown KE, Tisdale J, Barrett AJ, Dunbar CE, Young NS.
Hepatitis-associated aplastic anemia.
N Engl J Med 336(15): 1059-64, 1997.
[Text Abstract on PubMed]
|
|
|
106
|
Brown KE, Wong S, Buu M, Binh TV, Be TV, Young NS.
High prevalence of GB virus C/hepatitis G virus in healthy persons in Ho Chi Minh City, Vietnam.
J Infect Dis 175(2): 450-3, 1997.
[Text Abstract on PubMed]
|
|
|
107
|
Brown KE, Young NS.
Human parvovirus B19 infections in infants and children.
Adv Pediatr Infect Dis 13: 101-26, 1997.
[Text Abstract on PubMed]
|
|
|
108
|
Brown KE, Young NS.
Parvovirus B19 in human disease.
Annu Rev Med 48: 59-67, 1997.
[Text Abstract on PubMed]
|
|
|
109
|
Devetten MP, Liu JM, Ling V, Weichold FF, Yu J, Medof ME, Young NS, Dunn DE.
Paroxysmal nocturnal hemoglobinuria: new insights from murine Pig-a-deficient hematopoiesis.
Proc Assoc Am Physicians 109(2): 99-110, 1997.
[Text Abstract on PubMed]
|
|
|
110
|
Issaragrisil S, Chansung K, Kaufman DW, Sirijirachai J, Thamprasit T, Young NS.
Aplastic anemia in rural Thailand: its association with grain farming and agricultural pesticide exposure. Aplastic Anemia Study Group.
Am J Public Health 87(9): 1551-4, 1997.
[Text Abstract on PubMed]
|
|
|
111
|
Issaragrisil S, Kaufman D, Thongput A, Chansung K, Thamprasit T, Piankijagum A, Anderson T, Shapiro S, Leaverton P, Young NS.
Association of seropositivity for hepatitis viruses and aplastic anemia in Thailand.
Hepatology 25(5): 1255-7, 1997.
[Text Abstract on PubMed]
|
|
|
112
|
Issaragrisil S, Kaufman DW, Anderson T, Chansung K, Thamprasit T, Sirijirachai J, Piankijagum A, Porapakkham Y, Vannasaeng S, Leaverton PE, Shapiro S, Young NS.
Low drug attributability of aplastic anemia in Thailand. The Aplastic Anemia Study Group.
Blood 89(11): 4034-9, 1997.
[Text Abstract on PubMed]
|
|
|
113
|
Kaufman DW, Issaragrisil S, Anderson T, Chansung K, Thamprasit T, Sirijirachai J, Piankijagum A, Porapakkham Y, Vannasaeng S, Leaverton PE, Shapiro S, Young NS.
Use of household pesticides and the risk of aplastic anaemia in Thailand. The Aplastic Anemia Study Group.
Int J Epidemiol 26(3): 643-50, 1997.
[Text Abstract on PubMed]
|
|
|
114
|
Liu JM, Young NS, Walsh CE, Cottler-Fox M, Carter C, Dunbar C, Barrett AJ, Emmons R.
Retroviral mediated gene transfer of the Fanconi anemia complementation group C gene to hematopoietic progenitors of group C patients.
Hum Gene Ther 8(14): 1715-30, 1997.
[Text Abstract on PubMed]
|
|
|
115
|
Maciejewski JP, Sloand EM, Sato T, Anderson S, Young NS.
Impaired hematopoiesis in paroxysmal nocturnal hemoglobinuria/aplastic anemia is not associated with a selective proliferative defect in the glycosylphosphatidylinositol-anchored protein-deficient clone.
Blood 89(4): 1173-81, 1997.
[Text Abstract on PubMed]
|
|
|
116
|
Molldrem JJ, Caples M, Mavroudis D, Plante M, Young NS, Barrett AJ.
Antithymocyte globulin for patients with myelodysplastic syndrome.
Br J Haematol 99(3): 699-705, 1997.
[Text Abstract on PubMed]
|
|
|
117
|
Qazilbash MH, Liu JM, Vlachos A, Fruchtman S, Messner H, Zipursky A, Alter BP, Young NS.
A new syndrome of familial aplastic anemia and chronic liver disease.
Acta Haematol 97(3): 164-7, 1997.
[Text Abstract on PubMed]
|
|
|
118
|
Rosse WF, Young NS, Góngora-Biachi R.
[Hypoproliferative disorders of stem cells]
Rev Invest Clin 49 Suppl 1: 83-8, 1997.
[Text Abstract on PubMed]
|
|
|
119
|
Sato T, Selleri C, Anderson S, Young NS, Maciejewski JP.
Expression and modulation of cellular receptors for interferon-gamma, tumour necrosis factor, and Fas on human bone marrow CD34+ cells.
Br J Haematol 97(2): 356-65, 1997.
[Text Abstract on PubMed]
|
|
|
120
|
Sato T, Selleri C, Young NS, Maciejewski JP.
Inhibition of interferon regulatory factor-1 expression results in predominance of cell growth stimulatory effects of interferon-gamma due to phosphorylation of Stat1 and Stat3.
Blood 90(12): 4749-58, 1997.
[Text Abstract on PubMed]
|
|
|
121
|
Selleri C, Sato T, Del Vecchio L, Luciano L, Barrett AJ, Rotoli B, Young NS, Maciejewski JP.
Involvement of Fas-mediated apoptosis in the inhibitory effects of interferon-alpha in chronic myelogenous leukemia.
Blood 89(3): 957-64, 1997.
[Text Abstract on PubMed]
|
|
|
122
|
Selleri C, Sato T, Raiola AM, Rotoli B, Young NS, Maciejewski JP.
Induction of nitric oxide synthase is involved in the mechanism of Fas-mediated apoptosis in haemopoietic cells.
Br J Haematol 99(3): 481-9, 1997.
[Text Abstract on PubMed]
|
|
|
123
|
Sloand EM, Young NS, Kumar P, Weichold FF, Sato T, Maciejewski JP.
Role of Fas ligand and receptor in the mechanism of T-cell depletion in acquired immunodeficiency syndrome: effect on CD4+ lymphocyte depletion and human immunodeficiency virus replication.
Blood 89(4): 1357-63, 1997.
[Text Abstract on PubMed]
|
|
|
124
|
Sloand EM, Young NS, Sato T, Kumar P, Kim S, Weichold FF, Maciejewski JP.
Secondary colony formation after long-term bone marrow culture using peripheral blood and bone marrow of HIV-infected patients.
AIDS 11(13): 1547-53, 1997.
[Text Abstract on PubMed]
|
|
|
125
|
Young NS, Maciejewski J.
The pathophysiology of acquired aplastic anemia.
N Engl J Med 336(19): 1365-72, 1997.
[Text Abstract on PubMed]
|
|
|
126
|
Young NS.
Autoimmunity and its treatment in aplastic anemia.
Ann Intern Med 126(2): 166-8, 1997.
[Text Abstract on PubMed]
|
|
|
127
|
Brown KE, Young NS.
Parvoviruses and bone marrow failure.
Stem Cells 14(2): 151-63, 1996.
[Text Abstract on PubMed]
|
|
|
128
|
Chipman PR, Agbandje-McKenna M, Kajigaya S, Brown KE, Young NS, Baker TS, Rossmann MG.
Cryo-electron microscopy studies of empty capsids of human parvovirus B19 complexed with its cellular receptor.
Proc Natl Acad Sci U S A 93(15): 7502-6, 1996.
[Text Abstract on PubMed]
|
|
|
129
|
Dunbar CE, Young NS.
Gene marking and gene therapy directed at primary hematopoietic cells.
Curr Opin Hematol 3(6): 430-7, 1996.
[Text Abstract on PubMed]
|
|
|
130
|
Dunn DE, Yu J, Nagarajan S, Devetten M, Weichold FF, Medof ME, Young NS, Liu JM.
A knock-out model of paroxysmal nocturnal hemoglobinuria: Pig-a(-) hematopoiesis is reconstituted following intercellular transfer of GPI-anchored proteins.
Proc Natl Acad Sci U S A 93(15): 7938-43, 1996.
[Text Abstract on PubMed]
|
|
|
131
|
Emmons RV, Reid DM, Cohen RL, Meng G, Young NS, Dunbar CE, Shulman NR.
Human thrombopoietin levels are high when thrombocytopenia is due to megakaryocyte deficiency and low when due to increased platelet destruction.
Blood 87(10): 4068-71, 1996.
[Text Abstract on PubMed]
|
|
|
132
|
Kaufman DW, Kelly JP, Jurgelon JM, Anderson T, Issaragrisil S, Wiholm BE, Young NS, Leaverton P, Levy M, Shapiro S.
Drugs in the aetiology of agranulocytosis and aplastic anaemia.
Eur J Haematol Suppl 60: 23-30, 1996.
[Text Abstract on PubMed]
|
|
|
133
|
Maciejewski JP, Selleri C, Sato T, Anderson S, Young NS.
A severe and consistent deficit in marrow and circulating primitive hematopoietic cells (long-term culture-initiating cells) in acquired aplastic anemia.
Blood 88(6): 1983-91, 1996.
[Text Abstract on PubMed]
|
|
|
134
|
Maciejewski JP, Young NS, Yu M, Anderson SM, Sloand EM.
Analysis of the expression of glycosylphosphatidylinositol anchored proteins on platelets from patients with paroxysmal nocturnal hemoglobinuria.
Thromb Res 83(6): 433-47, 1996.
[Text Abstract on PubMed]
|
|
|
135
|
Mizukami H, Young NS, Brown KE.
Adeno-associated virus type 2 binds to a 150-kilodalton cell membrane glycoprotein.
Virology 217(1): 124-30, 1996.
[Text Abstract on PubMed]
|
|
|
136
|
Muramatsu S, Mizukami H, Young NS, Brown KE.
Nucleotide sequencing and generation of an infectious clone of adeno-associated virus 3.
Virology 221(1): 208-17, 1996.
[Text Abstract on PubMed]
|
|
|
137
|
Selleri C, Maciejewski JP, Sato T, Young NS.
Interferon-gamma constitutively expressed in the stromal microenvironment of human marrow cultures mediates potent hematopoietic inhibition.
Blood 87(10): 4149-57, 1996.
[Text Abstract on PubMed]
|
|
|
138
|
Young NS.
Drug-related blood dyscrasias. Introduction.
Eur J Haematol Suppl 60: 6-8, 1996.
[Text Abstract on PubMed]
|
|
|
139
|
Young NS.
Immune pathophysiology of acquired aplastic anaemia.
Eur J Haematol Suppl 60: 55-9, 1996.
[Text Abstract on PubMed]
|
|
|
140
|
Young NS.
Parvovirus infection and its treatment.
Clin Exp Immunol 104 Suppl 1: 26-30, 1996.
[Text Abstract on PubMed]
|
|
|
141
|
Anderson S, Momoeda M, Kawase M, Kajigaya S, Young NS.
Peptides derived from the unique region of B19 parvovirus minor capsid protein elicit neutralizing antibodies in rabbits.
Virology 206(1): 626-32, 1995.
[Text Abstract on PubMed]
|
|
|
142
|
Brown KE, Green SW, Young NS.
Goose parvovirus--an autonomous member of the dependovirus genus?
Virology 210(2): 283-91, 1995.
[Text Abstract on PubMed]
|
|
|
143
|
Brown KE, Young NS.
Parvovirus B19 infection and hematopoiesis.
Blood Rev 9(3): 176-82, 1995.
[Text Abstract on PubMed]
|
|
|
144
|
Gallinella G, Anderson SM, Young NS, Brown KE.
Human parvovirus B19 can infect cynomolgus monkey marrow cells in tissue culture.
J Virol 69(6): 3897-9, 1995.
[Text Abstract on PubMed]
|
|
|
145
|
Hibbs J, Young NS.
Viruses, virulence and pathogenicity.
Baillieres Clin Haematol 8(1): 1-23, 1995.
[Text Abstract on PubMed]
|
|
|
146
|
Kawase M, Momoeda M, Young NS, Kajigaya S.
Modest truncation of the major capsid protein abrogates B19 parvovirus capsid formation.
J Virol 69(10): 6567-71, 1995.
[Text Abstract on PubMed]
|
|
|
147
|
Kawase M, Momoeda M, Young NS, Kajigaya S.
Most of the VP1 unique region of B19 parvovirus is on the capsid surface.
Virology 211(2): 359-66, 1995.
[Text Abstract on PubMed]
|
|
|
148
|
Maciejewski J, Selleri C, Anderson S, Young NS.
Fas antigen expression on CD34+ human marrow cells is induced by interferon gamma and tumor necrosis factor alpha and potentiates cytokine-mediated hematopoietic suppression in vitro.
Blood 85(11): 3183-90, 1995.
[Text Abstract on PubMed]
|
|
|
149
|
Maciejewski JP, Selleri C, Sato T, Anderson S, Young NS.
Increased expression of Fas antigen on bone marrow CD34+ cells of patients with aplastic anaemia.
Br J Haematol 91(1): 245-52, 1995.
[Text Abstract on PubMed]
|
|
|
150
|
Maciejewski JP, Selleri C, Sato T, Cho HJ, Keefer LK, Nathan CF, Young NS.
Nitric oxide suppression of human hematopoiesis in vitro. Contribution to inhibitory action of interferon-gamma and tumor necrosis factor-alpha.
J Clin Invest 96(2): 1085-92, 1995.
[Text Abstract on PubMed]
|
|
|
151
|
Maciejewski JP, Weichold FF, Young NS, Cara A, Zella D, Reitz MS, Gallo RC.
Intracellular expression of antibody fragments directed against HIV reverse transcriptase prevents HIV infection in vitro.
Nat Med 1(7): 667-73, 1995.
[Text Abstract on PubMed]
|
|
|
152
|
Momoeda M, Kawase M, Young NS, Kajigaya S.
Purification of functional recombinant YY1 expressed in Sf9 insect cells.
Protein Expr Purif 6(2): 169-75, 1995.
[Text Abstract on PubMed]
|
|
|
153
|
Nagarajan S, Brodsky RA, Young NS, Medof ME.
Genetic defects underlying paroxysmal nocturnal hemoglobinuria that arises out of aplastic anemia.
Blood 86(12): 4656-61, 1995.
[Text Abstract on PubMed]
|
|
|
154
|
Rosenfeld SJ, Kimball J, Vining D, Young NS.
Intensive immunosuppression with antithymocyte globulin and cyclosporine as treatment for severe acquired aplastic anemia.
Blood 85(11): 3058-65, 1995.
[Text Abstract on PubMed]
|
|
|
155
|
Sato T, Selleri C, Young NS, Maciejewski JP.
Hematopoietic inhibition by interferon-gamma is partially mediated through interferon regulatory factor-1.
Blood 86(9): 3373-80, 1995.
[Text Abstract on PubMed]
|
|
|
156
|
Selleri C, Sato T, Anderson S, Young NS, Maciejewski JP.
Interferon-gamma and tumor necrosis factor-alpha suppress both early and late stages of hematopoiesis and induce programmed cell death.
J Cell Physiol 165(3): 538-46, 1995.
[Text Abstract on PubMed]
|
|
|
157
|
Smith TJ, Cullen JW, Peck SD, Brown KE, Young NS.
Pancytopenia secondary to parvovirus B19 infection in a child with acute lymphoblastic leukemia, mimicking leukemic relapse.
Am J Hematol 50(3): 226-7, 1995.
[Text Abstract on PubMed]
|
|
|
158
|
Young NS, Barrett AJ.
The treatment of severe acquired aplastic anemia.
Blood 85(12): 3367-77, 1995.
[Text Abstract on PubMed]
|
|
|
159
|
Young NS.
Aplastic anaemia.
Lancet 346(8969): 228-32, 1995.
[Text Abstract on PubMed]
|
|
|
160
|
Young NS.
B19 parvovirus.
Baillieres Clin Haematol 8(1): 25-56, 1995.
[Text Abstract on PubMed]
|
|
|
161
|
Agbandje M, Kajigaya S, McKenna R, Young NS, Rossmann MG.
The structure of human parvovirus B19 at 8 A resolution.
Virology 203(1): 106-15, 1994.
[Text Abstract on PubMed]
|
|
|
162
|
Brittenham GM, Griffith PM, Nienhuis AW, McLaren CE, Young NS, Tucker EE, Allen CJ, Farrell DE, Harris JW.
Efficacy of deferoxamine in preventing complications of iron overload in patients with thalassemia major.
N Engl J Med 331(9): 567-73, 1994.
[Text Abstract on PubMed]
|
|
|
163
|
Brodsky RA, Hasegawa S, Fibach E, Dunbar CE, Young NS, Rodgers GP.
Acquired sideroblastic anaemia following progesterone therapy.
Br J Haematol 87(4): 859-62, 1994.
[Text Abstract on PubMed]
|
|
|
164
|
Brown KE, Green SW, Antunez de Mayolo J, Bellanti JA, Smith SD, Smith TJ, Young NS.
Congenital anaemia after transplacental B19 parvovirus infection.
Lancet 343(8902): 895-6, 1994.
[Text Abstract on PubMed]
|
|
|
165
|
Brown KE, Hibbs JR, Gallinella G, Anderson SM, Lehman ED, McCarthy P, Young NS.
Resistance to parvovirus B19 infection due to lack of virus receptor (erythrocyte P antigen).
N Engl J Med 330(17): 1192-6, 1994.
[Text Abstract on PubMed]
|
|
|
166
|
Brown KE, Young NS, Liu JM.
Molecular, cellular and clinical aspects of parvovirus B19 infection.
Crit Rev Oncol Hematol 16(1): 1-31, 1994.
[Text Abstract on PubMed]
|
|
|
167
|
Frickhofen N, Chen ZJ, Young NS, Cohen BJ, Heimpel H, Abkowitz JL.
Parvovirus B19 as a cause of acquired chronic pure red cell aplasia.
Br J Haematol 87(4): 818-24, 1994.
[Text Abstract on PubMed]
|
|
|
168
|
Gallinella G, Young NS, Brown KE.
In situ hybridisation and in situ polymerase chain reaction detection of parvovirus B19 DNA within cells.
J Virol Methods 50(1-3): 67-74, 1994.
[Text Abstract on PubMed]
|
|
|
169
|
Goodman S, Xiao X, Donahue RE, Moulton A, Miller J, Walsh C, Young NS, Samulski RJ, Nienhuis AW.
Recombinant adeno-associated virus-mediated gene transfer into hematopoietic progenitor cells.
Blood 84(5): 1492-500, 1994.
[Text Abstract on PubMed]
|
|
|
170
|
Hartman KR, Brown KE, Green SW, Young NS.
Lack of evidence for parvovirus B19 viraemia in children with chronic neutropenia.
Br J Haematol 88(4): 895-6, 1994.
[Text Abstract on PubMed]
|
|
|
171
|
Liu JM, Buchwald M, Walsh CE, Young NS.
Fanconi anemia and novel strategies for therapy.
Blood 84(12): 3995-4007, 1994.
[Text Abstract on PubMed]
|
|
|
172
|
Maciejewski JP, Anderson S, Katevas P, Young NS.
Phenotypic and functional analysis of bone marrow progenitor cell compartment in bone marrow failure.
Br J Haematol 87(2): 227-34, 1994.
[Text Abstract on PubMed]
|
|
|
173
|
Maciejewski JP, Hibbs JR, Anderson S, Katevas P, Young NS.
Bone marrow and peripheral blood lymphocyte phenotype in patients with bone marrow failure.
Exp Hematol 22(11): 1102-10, 1994.
[Text Abstract on PubMed]
|
|
|
174
|
Maciejewski JP, Weichold FF, Young NS.
HIV-1 suppression of hematopoiesis in vitro mediated by envelope glycoprotein and TNF-alpha.
J Immunol 153(9): 4303-10, 1994.
[Text Abstract on PubMed]
|
|
|
175
|
Miller JL, Donahue RE, Sellers SE, Samulski RJ, Young NS, Nienhuis AW.
Recombinant adeno-associated virus (rAAV)-mediated expression of a human gamma-globin gene in human progenitor-derived erythroid cells.
Proc Natl Acad Sci U S A 91(21): 10183-7, 1994.
[Text Abstract on PubMed]
|
|
|
176
|
Miyamura K, Kajigaya S, Momoeda M, Smith-Gill SJ, Young NS.
Parvovirus particles as platforms for protein presentation.
Proc Natl Acad Sci U S A 91(18): 8507-11, 1994.
[Text Abstract on PubMed]
|
|
|
177
|
Momoeda M, Wong S, Kawase M, Young NS, Kajigaya S.
A putative nucleoside triphosphate-binding domain in the nonstructural protein of B19 parvovirus is required for cytotoxicity.
J Virol 68(12): 8443-6, 1994.
[Text Abstract on PubMed]
|
|
|
178
|
Nisticò A, Young NS.
gamma-Interferon gene expression in the bone marrow of patients with aplastic anemia.
Ann Intern Med 120(6): 463-9, 1994.
[Text Abstract on PubMed]
|
|
|
179
|
Rosenfeld SJ, Young NS, Alling D, Ayub J, Saxinger C.
Subunit interaction in B19 parvovirus empty capsids.
Arch Virol 136(1-2): 9-18, 1994.
[Text Abstract on PubMed]
|
|
|
180
|
Walsh CE, Grompe M, Vanin E, Buchwald M, Young NS, Nienhuis AW, Liu JM.
A functionally active retrovirus vector for gene therapy in Fanconi anemia group C.
Blood 84(2): 453-9, 1994.
[Text Abstract on PubMed]
|
|
|
181
|
Walsh CE, Nienhuis AW, Samulski RJ, Brown MG, Miller JL, Young NS, Liu JM.
Phenotypic correction of Fanconi anemia in human hematopoietic cells with a recombinant adeno-associated virus vector.
J Clin Invest 94(4): 1440-8, 1994.
[Text Abstract on PubMed]
|
|
|
182
|
Wong S, Momoeda M, Field A, Kajigaya S, Young NS.
Formation of empty B19 parvovirus capsids by the truncated minor capsid protein.
J Virol 68(7): 4690-4, 1994.
[Text Abstract on PubMed]
|
|
|
183
|
Bansal GP, Hatfield JA, Dunn FE, Kramer AA, Brady F, Riggin CH, Collett MS, Yoshimoto K, Kajigaya S, Young NS.
Candidate recombinant vaccine for human B19 parvovirus.
J Infect Dis 167(5): 1034-44, 1993.
[Text Abstract on PubMed]
|
|
|
184
|
Brittenham GM, Cohen AR, McLaren CE, Martin MB, Griffith PM, Nienhuis AW, Young NS, Allen CJ, Farrell DE, Harris JW.
Hepatic iron stores and plasma ferritin concentration in patients with sickle cell anemia and thalassemia major.
Am J Hematol 42(1): 81-5, 1993.
[Text Abstract on PubMed]
|
|
|
185
|
Brown KE, Anderson SM, Young NS.
Erythrocyte P antigen: cellular receptor for B19 parvovirus.
Science 262(5130): 114-7, 1993.
[Text Abstract on PubMed]
|
|
|
186
|
Hilfenhaus S, Cohen BJ, Bates C, Kajigaya S, Young NS, Zambon M, Mortimer PP.
Antibody capture haemadherence tests for parvovirus B19-specific IgM and IgG.
J Virol Methods 45(1): 27-37, 1993.
[Text Abstract on PubMed]
|
|
|
187
|
Liu JM, Auerbach AD, Anderson SM, Green SW, Young NS.
A trial of recombinant human superoxide dismutase in patients with Fanconi anaemia.
Br J Haematol 85(2): 406-8, 1993.
[Text Abstract on PubMed]
|
|
|
188
|
Maciejewski JP, Bruening EE, Donahue RE, Sellers SE, Carter C, Young NS, St Jeor S.
Infection of mononucleated phagocytes with human cytomegalovirus.
Virology 195(2): 327-36, 1993.
[Text Abstract on PubMed]
|
|
|
189
|
Saikawa T, Anderson S, Momoeda M, Kajigaya S, Young NS.
Neutralizing linear epitopes of B19 parvovirus cluster in the VP1 unique and VP1-VP2 junction regions.
J Virol 67(6): 3004-9, 1993.
[Text Abstract on PubMed]
|
|
|
190
|
Shimomura S, Wong S, Brown KE, Komatsu N, Kajigaya S, Young NS.
Early and late gene expression in UT-7 cells infected with B19 parvovirus.
Virology 194(1): 149-56, 1993.
[Text Abstract on PubMed]
|
|
|
191
|
Weinberger M, Hollingsworth H, Feuerstein IM, Young NS, Pizzo PA.
Successful surgical management of neutropenic enterocolitis in two patients with severe aplastic anemia. Case reports and review of the literature.
Arch Intern Med 153(1): 107-13, 1993.
[Text Abstract on PubMed]
|
|
|
192
|
Frickhofen N, Arnold R, Hertenstein B, Wiesneth M, Young NS.
Parvovirus B19 infection and bone marrow transplantation.
Ann Hematol 64 Suppl: A121-4, 1992.
[Text Abstract on PubMed]
|
|
|
193
|
Hibbs JR, Frickhofen N, Rosenfeld SJ, Feinstone SM, Kojima S, Bacigalupo A, Locasciulli A, Tzakis AG, Alter HJ, Young NS.
Aplastic anemia and viral hepatitis. Non-A, Non-B, Non-C?
JAMA 267(15): 2051-4, 1992.
[Text Abstract on PubMed]
|
|
|
194
|
Hibbs JR, Issaragrisil S, Young NS.
High prevalence of hepatitis C viremia among aplastic anemia patients and controls from Thailand.
Am J Trop Med Hyg 46(5): 564-70, 1992.
[Text Abstract on PubMed]
|
|
|
195
|
Hibbs JR, Young NS.
Viruses and the blood.
Baillieres Clin Haematol 5(2): 245-71, 1992.
[Text Abstract on PubMed]
|
|
|
196
|
Koziol DE, Kurtzman G, Ayub J, Young NS, Henderson DK.
Nosocomial human parvovirus B19 infection: lack of transmission from a chronically infected patient to hospital staff.
Infect Control Hosp Epidemiol 13(6): 343-8, 1992.
[Text Abstract on PubMed]
|
|
|
197
|
Liu JM, Green SW, Shimada T, Young NS.
A block in full-length transcript maturation in cells nonpermissive for B19 parvovirus.
J Virol 66(8): 4686-92, 1992.
[Text Abstract on PubMed]
|
|
|
198
|
Maciejewski JP, Bruening EE, Donahue RE, Mocarski ES, Young NS, St Jeor SC.
Infection of hematopoietic progenitor cells by human cytomegalovirus.
Blood 80(1): 170-8, 1992.
[Text Abstract on PubMed]
|
|
|
199
|
Maciejewski JP, Liu JM, Green SW, Walsh CE, Plumb M, Pragnell IB, Young NS.
Expression of stem cell inhibitor (SCI) gene in patients with bone marrow failure.
Exp Hematol 20(9): 1112-7, 1992.
[Text Abstract on PubMed]
|
|
|
200
|
Rosenfeld SJ, Yoshimoto K, Kajigaya S, Anderson S, Young NS, Field A, Warrener P, Bansal G, Collett MS.
Unique region of the minor capsid protein of human parvovirus B19 is exposed on the virion surface.
J Clin Invest 89(6): 2023-9, 1992.
[Text Abstract on PubMed]
|
|
|
201
|
Shimomura S, Komatsu N, Frickhofen N, Anderson S, Kajigaya S, Young NS.
First continuous propagation of B19 parvovirus in a cell line.
Blood 79(1): 18-24, 1992.
[Text Abstract on PubMed]
|
|
|
202
|
Walsh CE, Liu JM, Anderson SM, Rossio JL, Nienhuis AW, Young NS.
A trial of recombinant human interleukin-1 in patients with severe refractory aplastic anaemia.
Br J Haematol 80(1): 106-10, 1992.
[Text Abstract on PubMed]
|
|
|
203
|
Walsh CE, Liu JM, Xiao X, Young NS, Nienhuis AW, Samulski RJ.
Regulated high level expression of a human gamma-globin gene introduced into erythroid cells by an adeno-associated virus vector.
Proc Natl Acad Sci U S A 89(15): 7257-61, 1992.
[Text Abstract on PubMed]
|
|
|
204
|
Weinberger M, Elattar I, Marshall D, Steinberg SM, Redner RL, Young NS, Pizzo PA.
Patterns of infection in patients with aplastic anemia and the emergence of Aspergillus as a major cause of death.
Medicine (Baltimore) 71(1): 24-43, 1992.
[Text Abstract on PubMed]
|
|
|
205
|
Agbandje M, McKenna R, Rossmann MG, Kajigaya S, Young NS.
Preliminary X-ray crystallographic investigation of human parvovirus B19.
Virology 184(1): 170-4, 1991.
[Text Abstract on PubMed]
|
|
|
206
|
Dunbar CE, Smith DA, Kimball J, Garrison L, Nienhuis AW, Young NS.
Treatment of Diamond-Blackfan anaemia with haematopoietic growth factors, granulocyte-macrophage colony stimulating factor and interleukin 3: sustained remissions following IL-3.
Br J Haematol 79(2): 316-21, 1991.
[Text Abstract on PubMed]
|
|
|
207
|
Erdman DD, Usher MJ, Tsou C, Caul EO, Gary GW, Kajigaya S, Young NS, Anderson LJ.
Human parvovirus B19 specific IgG, IgA, and IgM antibodies and DNA in serum specimens from persons with erythema infectiosum.
J Med Virol 35(2): 110-5, 1991.
[Text Abstract on PubMed]
|
|
|
208
|
Frickhofen N, Young NS.
A rapid method of sample preparation for detection of DNA viruses in human serum by polymerase chain reaction.
J Virol Methods 35(1): 65-72, 1991.
[Text Abstract on PubMed]
|
|
|
209
|
Issaragrisil S, Sriratanasatavorn C, Piankijagum A, Vannasaeng S, Porapakkham Y, Leaverton PE, Kaufman DW, Anderson TE, Shapiro S, Young NS.
Incidence of aplastic anemia in Bangkok. The Aplastic Anemia Study Group.
Blood 77(10): 2166-8, 1991.
[Text Abstract on PubMed]
|
|
|
210
|
Kajigaya S, Fujii H, Field A, Anderson S, Rosenfeld S, Anderson LJ, Shimada T, Young NS.
Self-assembled B19 parvovirus capsids, produced in a baculovirus system, are antigenically and immunogenically similar to native virions.
Proc Natl Acad Sci U S A 88(11): 4646-50, 1991.
[Text Abstract on PubMed]
|
|
|
211
|
Liu JM, Auerbach AD, Young NS.
Fanconi anemia presenting unexpectedly in an adult kindred with no dysmorphic features.
Am J Med 91(5): 555-7, 1991.
[Text Abstract on PubMed]
|
|
|
212
|
Liu JM, Fujii H, Green SW, Komatsu N, Young NS, Shimada T.
Indiscriminate activity from the B19 parvovirus p6 promoter in nonpermissive cells.
Virology 182(1): 361-4, 1991.
[Text Abstract on PubMed]
|
|
|
213
|
Liu JM, Green SW, Hao YS, McDonagh KT, Young NS, Shimada T.
Upstream sequences within the terminal hairpin positively regulate the P6 promoter of B19 parvovirus.
Virology 185(1): 39-47, 1991.
[Text Abstract on PubMed]
|
|
|
214
|
Rosenfeld SJ, Young NS.
Viruses and bone marrow failure.
Blood Rev 5(2): 71-7, 1991.
[Text Abstract on PubMed]
|
|
|
215
|
Yoshimoto K, Rosenfeld S, Frickhofen N, Kennedy D, Hills R, Kajigaya S, Young NS.
A second neutralizing epitope of B19 parvovirus implicates the spike region in the immune response.
J Virol 65(12): 7056-60, 1991.
[Text Abstract on PubMed]
|
|
|
216
|
Young NS, Rosenfeld S, Antunez-de-Mayolo J, Hibbs J, Liu J, Maciejewski J, St Jeor S, Shimomura S, Kajigaya S.
Viruses and bone marrow failure.
Schweiz Med Wochenschr Suppl 43: 28-32, 1991.
[Text Abstract on PubMed]
|
|
|
217
|
Frickhofen N, Liu JM, Young NS.
Etiologic mechanisms of hematopoietic failure.
Am J Pediatr Hematol Oncol 12(4): 385-95, 1990.
[Text Abstract on PubMed]
|
|
|
218
|
Frickhofen N, Young NS.
Polymerase chain reaction for detection of parvovirus B19 in immunodeficient patients with anemia.
Behring Inst Mitt(85): 46-54, 1990.
[Text Abstract on PubMed]
|
|
|
219
|
Young NS.
Flaviviruses and bone marrow failure.
JAMA 263(22): 3065-8, 1990.
[Text Abstract on PubMed]
|
|
|
220
|
Young NS.
Hematopoietic growth factors: a summary of their biology in tissue culture, animals, and clinical trials.
Prog Clin Biol Res 337: 539-49, 1990.
[Text Abstract on PubMed]
|
|
|
221
|
Zoumbos NC, Baranski B, Young NS.
Different haematopoietic growth factors have different capacity in overcoming the in vitro interferon gamma-induced suppression of bone marrow progenitor cells.
Eur J Haematol 44(5): 282-90, 1990.
[Text Abstract on PubMed]
|
|
|
222
|
Frickhofen N, Young NS.
Persistent parvovirus B19 infections in humans.
Microb Pathog 7(5): 319-27, 1989.
[Text Abstract on PubMed]
|
|
|
223
|
Kajigaya S, Shimada T, Fujita S, Young NS.
A genetically engineered cell line that produces empty capsids of B19 (human) parvovirus.
Proc Natl Acad Sci U S A 86(19): 7601-5, 1989.
[Text Abstract on PubMed]
|
|
|
224
|
Kurtzman GJ, Cohen BJ, Field AM, Oseas R, Blaese RM, Young NS.
Immune response to B19 parvovirus and an antibody defect in persistent viral infection.
J Clin Invest 84(4): 1114-23, 1989.
[Text Abstract on PubMed]
|
|
|
225
|
Kurtzman GJ, Platanias L, Lustig L, Frickhofen N, Young NS.
Feline parvovirus propagates in cat bone marrow cultures and inhibits hematopoietic colony formation in vitro.
Blood 74(1): 71-81, 1989.
[Text Abstract on PubMed]
|
|
|
226
|
Leonard EM, Raefsky E, Griffith P, Kimball J, Nienhuis AW, Young NS.
Cyclosporine therapy of aplastic anaemia, congenital and acquired red cell aplasia.
Br J Haematol 72(2): 278-84, 1989.
[Text Abstract on PubMed]
|
|
|
227
|
Nakao S, Lai CJ, Young NS.
Dengue virus, a flavivirus, propagates in human bone marrow progenitors and hematopoietic cell lines.
Blood 74(4): 1235-40, 1989.
[Text Abstract on PubMed]
|
|
|
228
|
Young NS, Baranski B, Kurtzman G.
The immune system as mediator of virus-associated bone marrow failure: B19 parvovirus and Epstein-Barr virus.
Ann N Y Acad Sci 554: 75-80, 1989.
[Text Abstract on PubMed]
|
|
|
229
|
Baranski B, Armstrong G, Truman JT, Quinnan GV, Straus SE, Young NS.
Epstein-Barr virus in the bone marrow of patients with aplastic anemia.
Ann Intern Med 109(9): 695-704, 1988.
[Text Abstract on PubMed]
|
|
|
230
|
Bielory L, Gascon P, Lawley TJ, Young NS, Frank MM.
Human serum sickness: a prospective analysis of 35 patients treated with equine anti-thymocyte globulin for bone marrow failure.
Medicine (Baltimore) 67(1): 40-57, 1988.
[Text Abstract on PubMed]
|
|
|
231
|
Bielory L, Wright R, Nienhuis AW, Young NS, Kaliner MA.
Antithymocyte globulin hypersensitivity in bone marrow failure patients.
JAMA 260(21): 3164-7, 1988.
[Text Abstract on PubMed]
|
|
|
232
|
Kurtzman GJ, Cohen B, Meyers P, Amunullah A, Young NS.
Persistent B19 parvovirus infection as a cause of severe chronic anaemia in children with acute lymphocytic leukaemia.
Lancet 2(8621): 1159-62, 1988.
[Text Abstract on PubMed]
|
|
|
233
|
Kurtzman GJ, Gascon P, Caras M, Cohen B, Young NS.
B19 parvovirus replicates in circulating cells of acutely infected patients.
Blood 71(5): 1448-54, 1988.
[Text Abstract on PubMed]
|
|
|
234
|
Ettinghausen SE, Moore JG, White DE, Platanias L, Young NS, Rosenberg SA.
Hematologic effects of immunotherapy with lymphokine-activated killer cells and recombinant interleukin-2 in cancer patients.
Blood 69(6): 1654-60, 1987.
[Text Abstract on PubMed]
|
|
|
235
|
Kurtzman GJ, Ozawa K, Cohen B, Hanson G, Oseas R, Young NS.
Chronic bone marrow failure due to persistent B19 parvovirus infection.
N Engl J Med 317(5): 287-94, 1987.
[Text Abstract on PubMed]
|
|
|
236
|
Young NS, Leonard E, Platanias L.
Lymphocytes and lymphokines in aplastic anemia: pathogenic role and implications for pathogenesis.
Blood Cells 13(1-2): 87-100, 1987.
[Text Abstract on PubMed]
|
|
|
237
|
Young NS.
Gamma interferon and aplastic anemia.
Blood 70(1): 337-9, 1987.
[Text Abstract on PubMed]
|
|
|
238
|
Bielory L, Gascon P, Lawley TJ, Nienhuis A, Frank MM, Young NS.
Serum sickness and haematopoietic recovery with antithymocyte globulin in bone marrow failure patients.
Br J Haematol 63(4): 729-36, 1986.
[Text Abstract on PubMed]
|
|
|
239
|
Chorba T, Coccia P, Holman RC, Tattersall P, Anderson LJ, Sudman J, Young NS, Kurczynski E, Saarinen UM, Moir R.
The role of parvovirus B19 in aplastic crisis and erythema infectiosum (fifth disease).
J Infect Dis 154(3): 383-93, 1986.
[Text Abstract on PubMed]
|
|
|
240
|
Dover GJ, Humphries RK, Moore JG, Ley TJ, Young NS, Charache S, Nienhuis AW.
Hydroxyurea induction of hemoglobin F production in sickle cell disease: relationship between cytotoxicity and F cell production.
Blood 67(3): 735-8, 1986.
[Text Abstract on PubMed]
|
|
|
241
|
Raefsky EL, Gascon P, Gratwohl A, Speck B, Young NS.
Biological and immunological characterization of ATG and ALG.
Blood 68(3): 712-9, 1986.
[Text Abstract on PubMed]
|
|
|
242
|
Saarinen UM, Chorba TL, Tattersall P, Young NS, Anderson LJ, Palmer E, Coccia PF.
Human parvovirus B19-induced epidemic acute red cell aplasia in patients with hereditary hemolytic anemia.
Blood 67(5): 1411-7, 1986.
[Text Abstract on PubMed]
|
|
|
243
|
Young NS, Issaragrasil S, Chieh CW, Takaku F.
Aplastic anaemia in the Orient.
Br J Haematol 62(1): 1-6, 1986.
[Text Abstract on PubMed]
|
|
|
244
|
Bielory L, Yancey KB, Young NS, Frank MM, Lawley TJ.
Cutaneous manifestations of serum sickness in patients receiving antithymocyte globulin.
J Am Acad Dermatol 13(3): 411-7, 1985.
[Text Abstract on PubMed]
|
|
|
245
|
Gascon P, Zoumbos NC, Scala G, Djeu JY, Moore JG, Young NS.
Lymphokine abnormalities in aplastic anemia: implications for the mechanism of action of antithymocyte globulin.
Blood 65(2): 407-13, 1985.
[Text Abstract on PubMed]
|
|
|
246
|
Humphries RK, Dover G, Young NS, Moore JG, Charache S, Ley T, Nienhuis AW.
5-Azacytidine acts directly on both erythroid precursors and progenitors to increase production of fetal hemoglobin.
J Clin Invest 75(2): 547-57, 1985.
[Text Abstract on PubMed]
|
|
|
247
|
Lawley TJ, Bielory L, Gascon P, Yancey KB, Young NS, Frank MM.
A study of human serum sickness.
J Invest Dermatol 85(1 Suppl): 129s-132s, 1985.
[Text Abstract on PubMed]
|
|
|
248
|
Moore JG, Frank MM, Müller-Eberhard HJ, Young NS.
Decay-accelerating factor is present on paroxysmal nocturnal hemoglobinuria erythroid progenitors and lost during erythropoiesis in vitro.
J Exp Med 162(4): 1182-92, 1985.
[Text Abstract on PubMed]
|
|
|
249
|
Nienhuis AW, Ley TJ, Humphries RK, Young NS, Dover G.
Pharmacological manipulation of fetal hemoglobin synthesis in patients with severe beta-thalassemia.
Ann N Y Acad Sci 445: 198-211, 1985.
[Text Abstract on PubMed]
|
|
|
250
|
Raefsky EL, Platanias LC, Zoumbos NC, Young NS.
Studies of interferon as a regulator of hematopoietic cell proliferation.
J Immunol 135(4): 2507-12, 1985.
[Text Abstract on PubMed]
|
|
|
251
|
Zoumbos NC, Gascón P, Djeu JY, Trost SR, Young NS.
Circulating activated suppressor T lymphocytes in aplastic anemia.
N Engl J Med 312(5): 257-65, 1985.
[Text Abstract on PubMed]
|
|
|
252
|
Zoumbos NC, Gascon P, Djeu JY, Young NS.
Interferon is a mediator of hematopoietic suppression in aplastic anemia in vitro and possibly in vivo.
Proc Natl Acad Sci U S A 82(1): 188-92, 1985.
[Text Abstract on PubMed]
|
|
|
253
|
Gascón P, Zoumbos NC, Young NS.
Immunologic abnormalities in patients receiving multiple blood transfusions.
Ann Intern Med 100(2): 173-7, 1984.
[Text Abstract on PubMed]
|
|
|
254
|
Lawley TJ, Bielory L, Gascon P, Yancey KB, Young NS, Frank MM.
A prospective clinical and immunologic analysis of patients with serum sickness.
N Engl J Med 311(22): 1407-13, 1984.
[Text Abstract on PubMed]
|
|
|
255
|
Lawley TJ, Bielory L, Gascon P, Yancey KB, Young NS, Frank MM.
Human serum sickness.
Trans Assoc Am Physicians 97: 49-55, 1984.
[Text Abstract on PubMed]
|
|
|
256
|
Young NS, Moore JG, Humphries RK.
The human parvovirus and in vitro hematopoietic colony formation.
Prog Clin Biol Res 148: 129-39, 1984.
[Text Abstract on PubMed]
|
|
|
257
|
Young NS, Mortimer PP, Moore JG, Humphries RK.
Characterization of a virus that causes transient aplastic crisis.
J Clin Invest 73(1): 224-30, 1984.
[Text Abstract on PubMed]
|
|
|
258
|
Zoumbos NC, Djeu JY, Young NS.
Interferon is the suppressor of hematopoiesis generated by stimulated lymphocytes in vitro.
J Immunol 133(2): 769-74, 1984.
[Text Abstract on PubMed]
|
|
|
259
|
Ley TJ, Anagnou NP, Young NS, Nienhuis AW, DeSimone J, Heller P.
5-azacytidine for beta thalassaemia?
Lancet 1(8322): 467, 1983.
[Text Abstract on PubMed]
|
|
|
260
|
Young NS, Gallagher RE, Chen SP.
Anti-K562 monoclonal antibodies that recognize antigens on immature hematopoietic cells.
Prog Clin Biol Res 134: 293-304, 1983.
[Text Abstract on PubMed]
|
|
|
261
|
Young NS, Klein HG, Griffith P, Nienhuis AW.
A trial of immunotherapy in aplastic anemia and pure red cell aplasia.
J Clin Apher 1(2): 95-103, 1983.
[Text Abstract on PubMed]
|
|
|
262
|
Ley TJ, DeSimone J, Anagnou NP, Keller GH, Humphries RK, Turner PH, Young NS, Keller P, Nienhuis AW.
5-azacytidine selectively increases gamma-globin synthesis in a patient with beta+ thalassemia.
N Engl J Med 307(24): 1469-75, 1982.
[Text Abstract on PubMed]
|
|
|
263
|
Vembu D, Young NS, Willing M, Church E, Sanders-Haigh L, Anderson WF.
Regulation of human globin gene expression in mouse erythroleukemia x human fibroblast hybrid cells.
Somatic Cell Genet 8(2): 163-78, 1982.
[Text Abstract on PubMed]
|
|
|
264
|
Kienholz EW, Young NS, Smith JL, Whiteman CA.
Reduced vitamin a levels of chicks fed anaerobically digested sewage sludge.
Poult Sci 60(4): 884-6, 1981.
[Text Abstract on PubMed]
|
|
|
265
|
Young NS, Hwang-Chen SP.
Anti-K562 cell monoclonal antibodies recognize hematopoietic progenitors.
Proc Natl Acad Sci U S A 78(11): 7073-7, 1981.
[Text Abstract on PubMed]
|
|
|
266
|
Young NS.
Instrumentation.
Dent Hyg (Chic) 54(4): 186-96, 1980.
[Text Abstract on PubMed]
|
|
|
267
|
Young NS, Benz EJ, Kantor JA, Kretschmer P, Nienhuis AW.
Hemoglobin switching in sheep: only the gamma gene is in the active conformation in fetal liver but all the beta and gamma genes are in the active conformation in bone marrow.
Proc Natl Acad Sci U S A 75(12): 5884-8, 1978.
[Text Abstract on PubMed]
|
|
|
268
|
Curd JG, Young NS, Schechter AN.
Antibodies to an NH2-terminal fragment of betaS globin. II. Specificity and isolation of antibodies for the sickle mutation.
J Biol Chem 251(5): 1290-5, 1976.
[Text Abstract on PubMed]
|
|
|
269
|
Young NS, Eastlake A, Schechter AN.
The NH2-terminal region of the sickle hemoglobin beta chain. II. Characterization of monospecific antibodies.
J Biol Chem 251(20): 6431-8, 1976.
[Text Abstract on PubMed]
|
|
|
270
|
Zizic TM, Cwazka WF, Young NS, Stevens MB.
Urinary fibrin split products in lupus nephritis.
J Rheumatol 3(1): 43-9, 1976.
[Text Abstract on PubMed]
|
|
|
271
|
Young NS, Curd JG, Eastlake A, Furie B, Schechter AN.
Isolation of antibodies specific to sickle hemoglobin by affinity chromatography using a synthetic peptide.
Proc Natl Acad Sci U S A 72(12): 4759-63, 1975.
[Text Abstract on PubMed]
|
|
|
272
|
Levin J, Poore TE, Young NS, Margolis S, Zauber NP, Townes AS, Bell WR.
Gram-negative sepsis: detection of endotoxemia with the limulus test. With studies of associated changes in blood coagulation, serum lipids, and complement.
Ann Intern Med 76(1): 1-7, 1972.
[Text Abstract on PubMed]
|
|
|
273
|
Young NS, Levin J, Prendergast RA.
An invertebrate coagulation system activated by endotoxin: evidence for enzymatic mediation.
J Clin Invest 51(7): 1790-7, 1972.
[Text Abstract on PubMed]
|
|
|
274
|
Baranski BG, Young NS.
Autoimmune aspects of aplastic anemia.
In Vivo 2(1): 91-4,
[Text Abstract on PubMed]
|
|
|
275
|
Mortimer PP, Humphries RK, Moore JG, Purcell RH, Young NS.
A human parvovirus-like virus inhibits haematopoietic colony formation in vitro.
Nature 302(5907): 426-9,
[Text Abstract on PubMed]
|
|
|
276
|
Risitano AM, Maciejewski JP, Green S, Plasilova M, Zeng W, Young NS.
In-vivo dominant immune responses in aplastic anaemia: molecular tracking of putatively pathogenetic T-cell clones by TCR beta-CDR3 sequencing.
Lancet 364(9431): 355-64,
[Text Abstract on PubMed]
|
|
|
277
|
Yamaguchi H, Aridgides LJ, Zeng W, Osgood C, Young NS, Liu JM.
Genetic and transcriptional analysis of spindle checkpoint genes in bone marrow failure patients.
Blood Cells Mol Dis 30(3): 307-11,
[Text Abstract on PubMed]
|
|
|
278
|
Young NS.
Agranulocytosis.
JAMA 271(12): 935-8,
[Text Abstract on PubMed]
|
|
|